The table provides details of approved research proposals that have published or presented their results.
|Data Request ID||Lead Investigator||Institution||Research Proposal Title||Publication|
|4036||Akira Kimata||University of Tsukuba||Optimal interruption time of dabigatran per OS to Ablation (O-A time) in patients with atrial fibrillation Integrated analysis of 2 randomized controlled clinical trials||Circulation. Late-Breaking Science Abstracts and Featured Science Abstracts From the American Heart Association’s Scientific Sessions 2019 and Late-Breaking Abstracts in Resuscitation Science From the Resuscitation Science Symposium 2019, Volume: 140, Issue: 25, Pages: e965-e1011, DOI: (10.1161/CIR.0000000000000742)
|3320||John Frew||Rockefeller University||Analysis of Outcome Measures in Hidradenitis Suppurativa/||Clinical Response Rates, Placebo Response Rates and Significantly Associated Covariates Are Dependent Upon Choice of Outcome Measure in Hidradenitis Suppurativa: A Post-Hoc Analysis of PIONEER 1 and 2 Individual Patient Data
Frew, John W. et al.
Journal of the American Academy of Dermatology, Volume 0, Issue 0
Publications about Vivli and Data Sharing
Li, R. (2019). Move Clinical Trial Data Sharing from an Option to an Imperative – STAT First Opinion. [online] STAT.
Li, R., J. Scott, F. Rockhold, N. Hill, J. Wood, and I. Sim. (2018). Moving Data Sharing Forward: The Launch of the Vivli Platform . NAM Perspectives. Commentary, National Academy of Medicine, Washington, DC.